Sanofi
SAN.PA · PAR
Bulios Fair Price
41.53 €
44.0% downside
Current Price
74.13 €
According to Bulios Fair Price, SAN.PA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Sanofi (SNY) is a global pharmaceutical company headquartered in France. It focuses on research, development, manufacturing, and distribution of medicinal products in various therapeutic areas. Sanofi has a broad portfolio of pharmaceutical products, including medications for cardiovascular diseases, respiratory diseases, diabetes, immune system disorders, and more. The company is known for its innovative drugs and vaccines that contribute to the improvement of global healthcare. With a long history, extensive research efforts, and a strong global presence, Sanofi has become a key player in the pharmaceutical market. Sanofi (SNY) shares represent an attractive investment opportunity for investors seeking a stable and promising investment in the healthcare sector.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Belén Garijo López
Employees
74,846
Headquarters
Paris
Upcoming events
Earnings
Upcoming earnings report